13F filer · CIK 1037792 ↗
Paradigm Capital Management Inc
You are looking at Q1 2025. See the latest, Q2 2026 →
Reported value
$1.80B
−17% on the quarter before
Positions
127
7 new · 8 sold out
Top 10
50.7%
of the value
Est. gain
−$319.9M
on stocks held all quarter
Est. return
−15.7%
on those stocks since Q4 2024
Positions as of Mar 31, 2025, from Paradigm Capital Management Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2024. Striped tiles are options.
Largest buys
Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Quidel Corp~$14.0MAdded · 0.1% → 0.9%+399,500 shares
- Penguin Solutions Inc~$13.4MAdded · 0.3% → 1.1%+769,200 shares
- Enovis Corporation~$9.7MAdded · 1.1% → 1.7%+253,200 shares
- Veeco Instruments~$8.0MAdded · 2.5% → 2.7%+397,200 shares
- FormFactor~$7.3MAdded · 0.1% → 0.5%+257,600 shares
- Semtech~$6.6MNew · 0.0% → 0.4%+191,600 shares
- Orthopediatrics Corp~$4.0MAdded · 0.0% → 0.2%+160,700 shares
- American Woodmark Corporation~$3.3MAdded · 1.1% → 1.2%+55,711 shares
- Revvity Inc.~$2.6MAdded · 0.1% → 0.2%+25,000 shares
- Ultra Clean Holdings Inc~$2.1MAdded · 1.1% → 0.9%+100,000 shares
Largest sells
Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Summit Materials, Inc. Class A~$42.9MSold out · 2.0% → 0.0%−847,890 shares
- Adtran Inc~$20.4MCut · 0.9% → 0.0%−2,339,600 shares
- Smurfit Westrock L~$12.6MCut · 0.9% → 0.2%−280,700 shares
- Kratos Defense~$7.5MCut · 0.7% → 0.5%−252,300 shares
- Ducommun Inc~$3.9MCut · 3.2% → 3.3%−66,900 shares
- Angiodynamics, Inc.~$3.7MSold out · 0.2% → 0.0%−404,001 shares
- Ocular Therapeutix Inc.~$3.4MSold out · 0.2% → 0.0%−400,000 shares
- Eton Pharmaceuticals, Inc.~$2.7MSold out · 0.1% → 0.0%−200,000 shares
- Ribbon Communications Inc~$2.5MCut · 2.0% → 2.1%−627,421 shares
- Citi Trends, Inc.~$2.1MCut · 0.2% → 0.1%−92,972 shares
Holdings
As of Mar 31, 2025. Changes are in shares against Dec 31, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BroadcomCOM · shares 0% · price −27.8% | 7.5% | $135.5M | −$52.1M | ||||||||
| Onto InnovationCOM · shares 0% · price −27.2% | 7.4% | $134.1M | −$50.1M | ||||||||
| ModineCOM · shares −0.05% · price −33.8% | 7.0% | $126.4M | −$64.5M | ||||||||
| FabrinetCOM · shares −0.08% · price −10.2% | 5.8% | $105.0M | −$11.9M | ||||||||
| Insight EnterprisesCOM · shares 0% · price −1.4% | 5.0% | $89.4M | −$1.3M | ||||||||
| JabilCOM · shares −0.3% · price −5.4% | 4.3% | $77.7M | −$4.5M | ||||||||
| Globus MedicalCOM · shares 0% · price −11.5% | 3.9% | $69.5M | −$9.0M | ||||||||
| Extreme NetworksCOM · shares +0.7% · price −21.0% | 3.8% | $69.1M | −$18.2M | ||||||||
| Ducommun IncCOM · shares −6.2% · price −8.8% | 3.3% | $59.0M | −$5.7M | ||||||||
| Veeco InstrumentsCOM · shares +20% · price −25.1% | 2.7% | $47.8M | −$13.3M | ||||||||
| EntegrisCOM · shares 0% · price −11.7% | 2.6% | $46.9M | −$6.2M | ||||||||
| Ensign Group, Inc.COM · shares +0.2% · price −2.6% | 2.5% | $44.9M | −$1.2M | ||||||||
| EnersysCOM · shares +1.1% · price −0.9% | 2.5% | $44.3M | −$406,276 | ||||||||
| Concentrix CorpCOM · shares −0.3% · price +28.6% | 2.3% | $41.6M | +$9.3M | ||||||||
| Orthofix Medical Inc.COM · shares −0.2% · price −6.6% | 2.2% | $40.5M | −$2.9M | ||||||||
| Ribbon Communications IncCOM · shares −6.2% · price −5.8% | 2.1% | $37.3M | −$2.3M | ||||||||
| Calix IncCOM · shares −2.8% · price +1.6% | 2.0% | $36.4M | +$585,561 | ||||||||
| MimedxCOM · shares −0.06% · price −21.0% | 2.0% | $35.6M | −$9.5M | ||||||||
| Integra Lifesciences Holdings CorpCOM · shares −3.2% · price −3.0% | 1.7% | $30.5M | −$955,788 | ||||||||
| Enovis CorporationCOM · shares +47% · price −12.9% | 1.7% | $30.0M | −$3.0M | ||||||||
| Enviri CorpCOM · shares −0.1% · price −13.6% | 1.7% | $29.7M | −$4.7M | ||||||||
| Pennant Group Inc.COM · shares +1.7% · price −5.2% | 1.3% | $24.0M | −$1.3M | ||||||||
| American Woodmark CorporationCOM · shares +18% · price −26.0% | 1.2% | $21.0M | −$6.2M | ||||||||
| Tactile Systems TechnologyCOM · shares −8.0% · price −22.8% | 1.1% | $20.2M | −$6.0M | ||||||||
| CerenceCOM · shares −2.0% · price +0.6% | 1.1% | $20.1M | +$127,110 | ||||||||
| Total · 127 positions | 100% | $1.80B | −$319.9M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2024 to Q1 2025: 120 stocks held throughout, down $319.9M (−15.7%).
- Concentrix Corp+$9.3M+29%
- Xerox Corp25:1 split+$5.6M+1,332%
- Cohu Inc.2:1 split+$1.3M+10%
- Kratos Defense+$1.0M+13%
- Johnson & Johnson+$609,014+15%
- Veeco Instruments−$13.3M−25%
- Extreme Networks−$18.2M−21%
- Onto Innovation−$50.1M−27%
- Broadcom−$52.1M−28%
- Modine−$64.5M−34%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $3.67B+41% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $2.61B+10% | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | $2.38B+3% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $2.31B+12% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $2.05B+14% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $1.80B−17% | SEC ↗ |
| Q4 2024 | Feb 18, 2025 | $2.16B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.25B+3% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.19B+5% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $2.09B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.92B+10% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.74B−0% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.75B+16% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $1.51B−0% | SEC ↗ |
| Q4 2022 | Feb 3, 2023 | $1.51B+9% | SEC ↗ |
| Q3 2022 | Oct 26, 2022 | $1.39B−6% | SEC ↗ |
| Q2 2022 | Aug 2, 2022 | $1.47B−20% | SEC ↗ |
| Q1 2022 | May 25, 2022 | $1.85B−17% | SEC ↗ |
| Q4 2021 | Feb 9, 2022 | $2.24B+15% | SEC ↗ |
| Q3 2021 | Nov 8, 2021 | $1.94B−7% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $2.08B+8% | SEC ↗ |
| Q1 2021 | May 5, 2021 | $1.93B+15% | SEC ↗ |
| Q4 2020 | Jan 20, 2021 | $1.67B+41% | SEC ↗ |
| Q3 2020 | Oct 20, 2020 | $1.19B+9% | SEC ↗ |
| Q2 2020 | Aug 3, 2020 | $1.09B+32% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $827.9M−36% | SEC ↗ |
| Q4 2019 | Feb 5, 2020 | $1.30B+16% | SEC ↗ |
| Q3 2019 | Nov 7, 2019 | $1.12B+2% | SEC ↗ |
| Q2 2019 | Aug 8, 2019 | $1.10B−4% | SEC ↗ |
| Q1 2019 | May 10, 2019 | $1.14B+12% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $1.02B−20% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $1.27B+3% | SEC ↗ |
| Q2 2018 | Aug 8, 2018 | $1.24B+5% | SEC ↗ |
| Q1 2018 | Apr 9, 2018 | $1.18B+1% | SEC ↗ |
| Q4 2017 | Feb 7, 2018 | $1.17B+2% | SEC ↗ |
| Q3 2017 | Nov 6, 2017 | $1.15B+4% | SEC ↗ |
| Q2 2017 | Aug 10, 2017 | $1.11B+5% | SEC ↗ |
| Q1 2017 | May 9, 2017 | $1.06B+3% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $1.03B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $953.0M+16% | SEC ↗ |
| Q2 2016 | Aug 9, 2016 | $820.6M−4% | SEC ↗ |
| Q1 2016 | May 12, 2016 | $858.8M | SEC ↗ |